A61K36/232

CORROSION-RESISTANT AND LEAK-PROOF STOMA PASTE WITH SELF-REGULATION OF STRENGTH AND PREPARATION METHOD
20220339325 · 2022-10-27 · ·

A corrosion-resistant and leak-proof stoma paste with self-regulation of strength is provided in this disclosure, with a formula comprising 4-40 parts of liquid rubber with a molecular weight ranging from 2000 to 5000, 8-18 parts of mineral oil, 14-34 parts of iota-carrageenan, 10-20 parts of plant polysaccharide and 15-20 parts of sericite, by weight. A product of the present disclosure can self-regulate hardness of the paste according to amount of stoma excreta through cooperation of the iota-carrageenan and the sericite to improve corrosion resistance of the paste; and synergistic effect provided by the iota-carrageenan and the sericite powder can improve strength and corrosion resistance of the paste.

CORROSION-RESISTANT AND LEAK-PROOF STOMA PASTE WITH SELF-REGULATION OF STRENGTH AND PREPARATION METHOD
20220339325 · 2022-10-27 · ·

A corrosion-resistant and leak-proof stoma paste with self-regulation of strength is provided in this disclosure, with a formula comprising 4-40 parts of liquid rubber with a molecular weight ranging from 2000 to 5000, 8-18 parts of mineral oil, 14-34 parts of iota-carrageenan, 10-20 parts of plant polysaccharide and 15-20 parts of sericite, by weight. A product of the present disclosure can self-regulate hardness of the paste according to amount of stoma excreta through cooperation of the iota-carrageenan and the sericite to improve corrosion resistance of the paste; and synergistic effect provided by the iota-carrageenan and the sericite powder can improve strength and corrosion resistance of the paste.

CORROSION-RESISTANT AND LEAK-PROOF STOMA PASTE WITH SELF-REGULATION OF STRENGTH AND PREPARATION METHOD
20220339325 · 2022-10-27 · ·

A corrosion-resistant and leak-proof stoma paste with self-regulation of strength is provided in this disclosure, with a formula comprising 4-40 parts of liquid rubber with a molecular weight ranging from 2000 to 5000, 8-18 parts of mineral oil, 14-34 parts of iota-carrageenan, 10-20 parts of plant polysaccharide and 15-20 parts of sericite, by weight. A product of the present disclosure can self-regulate hardness of the paste according to amount of stoma excreta through cooperation of the iota-carrageenan and the sericite to improve corrosion resistance of the paste; and synergistic effect provided by the iota-carrageenan and the sericite powder can improve strength and corrosion resistance of the paste.

Oriental medicine composition effective for thyroid hormone level normalization
11478523 · 2022-10-25 ·

The present disclosure relates to an oriental medicine composition effective for thyroid hormone level normalization, and more particularly, to an oriental medicine composition for treating thyroid diseases, such as hypothyroidism or hyperthyroidism.

Oriental medicine composition effective for thyroid hormone level normalization
11478523 · 2022-10-25 ·

The present disclosure relates to an oriental medicine composition effective for thyroid hormone level normalization, and more particularly, to an oriental medicine composition for treating thyroid diseases, such as hypothyroidism or hyperthyroidism.

Oriental medicine composition effective for thyroid hormone level normalization
11478523 · 2022-10-25 ·

The present disclosure relates to an oriental medicine composition effective for thyroid hormone level normalization, and more particularly, to an oriental medicine composition for treating thyroid diseases, such as hypothyroidism or hyperthyroidism.

A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR THE TREATMENT OR ALLEVIATION OF SKIN ULCER AND THE USE THEREOF
20230127213 · 2023-04-27 ·

The present invention is related to a topical pharmaceutical composition and cosmetic composition comprising a combined herb extract of Longanae Arillus,Ligustici Tenuissimi Rhizomaand Polygalae radix as an active ingredient to treat and alleviate skin ulcer.

A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR THE TREATMENT OR ALLEVIATION OF SKIN ULCER AND THE USE THEREOF
20230127213 · 2023-04-27 ·

The present invention is related to a topical pharmaceutical composition and cosmetic composition comprising a combined herb extract of Longanae Arillus,Ligustici Tenuissimi Rhizomaand Polygalae radix as an active ingredient to treat and alleviate skin ulcer.

Microemulsion Delivery Systems for Alcohol-Soluble Species Including DHEA, Pregnenolone, and Chrysin for Reducing Menopausal Symptoms

Microemulsions are described where hydrophobic liquid droplets are distributed in a continuous hydrophilic liquid phase. In relation to conventional oil-in-water (OIW) microemulsions, the described microemulsions may be thought of as modified oil-in-water (MOIW) microemulsions, where both the “oil” and “water” phases of the microemulsion are modified. The oil phase droplets of the MOIW microemulsion are modified with alcohol and can solubilize alcohol-soluble species, including nonderivatized hormones. More preferably, the modified oil phase droplets of the MOIW microemulsion directly solubilize nonderivatized hormones. The oil phase droplets of the MOIW microemulsion include DHEA, pregnenolone, and a polyphenol, where a ratio of DHEA to polyphenol is from 1:1 to 12:1 by weight. Methods of supporting and/or increasing bloodstream hormone levels in perimenopausal and postmenopausal females and improving menopausal symptoms also are disclosed.

Microemulsion Delivery Systems for Alcohol-Soluble Species Including DHEA, Pregnenolone, and Chrysin for Reducing Menopausal Symptoms

Microemulsions are described where hydrophobic liquid droplets are distributed in a continuous hydrophilic liquid phase. In relation to conventional oil-in-water (OIW) microemulsions, the described microemulsions may be thought of as modified oil-in-water (MOIW) microemulsions, where both the “oil” and “water” phases of the microemulsion are modified. The oil phase droplets of the MOIW microemulsion are modified with alcohol and can solubilize alcohol-soluble species, including nonderivatized hormones. More preferably, the modified oil phase droplets of the MOIW microemulsion directly solubilize nonderivatized hormones. The oil phase droplets of the MOIW microemulsion include DHEA, pregnenolone, and a polyphenol, where a ratio of DHEA to polyphenol is from 1:1 to 12:1 by weight. Methods of supporting and/or increasing bloodstream hormone levels in perimenopausal and postmenopausal females and improving menopausal symptoms also are disclosed.